Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Endocrinology and Metabolism|December 19, 2013
Validation of surrogate indexes of insulin sensitivity in acute phase of myocardial infarction based on euglycemic-hyperinsulinemic clampFilipe A Moura, Luiz Sergio F Carvalho, Riobaldo M R Cintra, et al.
Diabetes, Obesity & Metabolism|July 26, 2024
Risk of new-onset diabetes and efficacy of pharmacological weight loss therapyFilipe A Moura, Andrea Bellavia, David D Berg, et al.
Diabetes, Obesity & Metabolism|April 28, 2026
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver FibrosisJan Oscarsson, Monika Huhn, Yunyun Jiang, et al.
International Journal of General Medicine|July 29, 2021
Defective Allele of the Neuronal Nitric Oxide Synthase Gene Increases Insulin Resistance During Acute Phase of Myocardial InfarctionOtávio T Nóbrega, Alessandra M Campos-Staffico, Elayne Kelen Oliveira, et al.
Diabetes Care|August 9, 2023
Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 DiabetesFilipe A Moura, David D Berg, Andrea Bellavia, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 23, 2019
Excess weight mediates changes in HDL pool that reduce cholesterol efflux capacity and increase antioxidant activityJose Carlos de Lima-Junior, Vitor W M Virginio, Filipe A Moura, et al.
American Heart Journal|March 10, 2025
Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemiaNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
BBA Clinical|May 24, 2016
TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarctionRiobaldo Cintra, Filipe A Moura, Luiz S F Carvalho, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
American Heart Journal|March 13, 2025
Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trialBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Pageof 5